We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+7.8%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$484B
AUM Growth
+$29.1B
Cap. Flow
-$16.6B
Cap. Flow %
-3.43%
Top 10 Hldgs %
36.47%
Holding
15,826
New
1,205
Increased
5,575
Reduced
7,223
Closed
1,563

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$545M
2
DXCM icon
DexCom
DXCM
+$457M
3
T icon
AT&T
T
+$431M
4
PANW icon
Palo Alto Networks
PANW
+$416M
5
HUM icon
Humana
HUM
+$394M

Sector Composition

Rank Sector Weight
1 Technology 3.01%
2 Healthcare 2.92%
3 Consumer Discretionary 1.99%
4 Financials 1.93%
5 Industrials 1.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIOR
15701
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
-139
Closed -$4.9K
AMPE
15702
CALL
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
-389
Closed -$1.81K
AMPE
15703
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
-382
Closed -$1.78K
ATHX
15704
DELISTED
Athersys, Inc. Common Stock
ATHX
-551
Closed -$497
XELA
15705
DELISTED
Exela Technologies, Inc. Common Stock
XELA
-33
Closed -$201
NBRV
15706
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
-11,607
Closed -$20.1K
VISL
15707
CALL
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
-2,000
Closed -$13.8K
VISL
15708
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
-11,782
Closed -$81.3K
VISL
15709
PUT
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
-355
Closed -$2.45K
NAVB
15710
CALL
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
-2,400
Closed -$624
NAVB
15711
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
-65,807
Closed -$17.1K
NAVB
15712
PUT
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
-300
Closed -$78
CO
15713
CALL
DELISTED
Global Cord Blood Corporation
CO
-6,100
Closed -$18.2K
CO
15714
DELISTED
Global Cord Blood Corporation
CO
-10,800
Closed -$32.3K
CEI
15715
DELISTED
Camber Energy, Inc
CEI
-590
Closed -$704
CIZ
15716
DELISTED
VictoryShares Developed Enhanced Volatility Wtd ETF
CIZ
-25,359
Closed -$789K
CTIC
15717
CALL
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
-80,900
Closed -$340K
CTIC
15718
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
-3,662
Closed -$15.4K
CTIC
15719
PUT
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
-42,800
Closed -$180K
MNTX
15720
PUT
DELISTED
Manitex International, Inc.
MNTX
-100
Closed -$521
ATIP
15721
CALL
DELISTED
ATI Physical Therapy, Inc.
ATIP
-1,846
Closed -$23.5K
ATIP
15722
DELISTED
ATI Physical Therapy, Inc.
ATIP
-231
Closed -$2.94K
ATIP
15723
PUT
DELISTED
ATI Physical Therapy, Inc.
ATIP
-24
Closed -$305
MSSAU
15724
DELISTED
Metal Sky Star Acquisition Corporation Unit
MSSAU
-13,581
Closed -$153K
FIACW
15725
DELISTED
Focus Impact Acquisition Corp. Warrant
FIACW
-14,415
Closed -$505

Similar funds

Ken Griffin's Q2 2023 Portfolio in Review

As of Q2 2023, Ken Griffin held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Ken Griffin withdrew a net $16.6B in Q2 2023, closing 1,563 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Ken Griffin opened a new position in BILL Holdings worth $222M.

  • Ken Griffin's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
  • Ken Griffin added most to Microsoft in Q2 2023, an estimated $640M increase.
  • Ken Griffin's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
  • Ken Griffin fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
  • Ken Griffin's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
  • Ken Griffin opened 1,205 new positions and closed 1,563 in Q2 2023.
  • Ken Griffin's portfolio value rose 6.4% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.